Virpax Pharmaceuticals
(OTC) VRPX
Virpax Pharmaceuticals Financials at a Glance
Market Cap
$600
Revenue (TTM)
$0.00
Net Income (TTM)
$12.07M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-1111.29 (Low)
Dividend
$0.00
Beta (Volatility)
-1111.29 (Low)
Price
$0.00
Volume
66
Open
$0.00
Price
$0.00
Volume
66
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.48
Dividend
$0.00
Beta (Volatility)
-1111.29 (Low)
Price
$0.00
Volume
66
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.48
VRPX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Virpax Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
2
CEO
Jay Dhaliwal
Website
www.virpaxpharma.comHeadquarters
Berwyn, PA 19312, US
VRPX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
13%
Return on Assets
-8%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$600.00
Shares Outstanding
1.24M
Volume
66
Short Interest
0.00%
Avg. Volume
421.557
Financials (TTM)
Gross Profit
$0.00
Operating Income
$12.08M
EBITDA
$11.96M
Operating Cash Flow
$16.71B
Capital Expenditure
$0.00
Free Cash Flow
$16.71B
Cash & ST Invst.
$1.51M
Total Debt
$0.00
Virpax Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$600.00
N/A
Market Cap/Employee
$300.00
N/A
Employees
2
N/A
Net Income
$3.39M
+25.7%
EBITDA
$3.39M
+25.7%
Quarterly Fundamentals
Net Cash
$1.51M
-83.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-7.76%
N/A
Return on Invested Capital
13.22%
N/A
Free Cash Flow
$2.87M
+4.7%
Operating Cash Flow
$2.87M
+4.7%